CSI Market
Sign In | Register

Bionik Laboratories (BNKL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BNKL Annual Cash Flow →
The data below summarizes Bionik Laboratories's cash flow activity from Mar 31 2022 to Mar 31 2023, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2023)
12 Months 		(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Operating Activities
Income-4.95
Depreciation & amortization0.06
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.08
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.08
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.31
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Accrued Payables-
Goodwill Written Off Related To Sale Of Business Unit-
Accounts Receivable-
Accrued Payables-
Write Off Of Inventory-
Allowance For Loan And Lease Losses Write Offs-
Imputed Interest-
Interest Income Expense Net0.05
Share Premium Expense-
Gains Losses On Restructuring Of Debt-
Goodwill And Intangible Asset Impairment-
Increase Or Decrease In Net Book Value Of Demonstration Inventory Sold-
Increase Decrease In Operating Lease0.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.18
Increase (Decrease) in Accounts Payable0.26
Increase (Decrease) in Accrued Liabilities0.51
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other0.26
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.07
Discontinued operations0.00
Net Cash flow from Operating Activities-3.39
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Other Non Current Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-0.22
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for (Proceeds from) Loans Receivable, Total0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.22
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings2.05
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Interest And Debt Expense-
Notes Payable Borrowing-
Sales Of Common Stock-
Note Payable Borrowing-
Sales Of Common Stock-
Repayment Of Promissiory Notes Interest-
Financing Cash Acquired On Acquisition-
Financingcashacquiredonacquisition-
Repaymentofpromissiorynotesinterest-
Repaymentsofdemandnotesprincipal-
Repaymentsofdemandnotesinterest-
Repayments Of Short Term Loan Interest-
Repayments Of Dem and Notes Principal-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.05
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.39
Total Cash Flow-1.56
4 historic quarters locked

Sign in to unlock the full Bionik Laboratories cash flow history.

Sign In Create Free Account

About Bionik Laboratories Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001410578-23-001453

Figures are derived from filed reports and may be restated. Historical data is subject to revision.